Adolescent and Adult Participation in an HIV Vaccine Trial Preparedness Cohort in South Africa

Journal of Adolescent Health

Volumn 43, Issue 1, 2008, Pages 8-14

  Middelkoop, Keren ^a   Myer, Landon ^a,b   Mark, Daniella ^a   Mthimunye, Sibonisile P ^a   Smit, Joalida ^a   Wood, Robin ^a   Bekker, Linda Gail ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Columbia University ^*  (United States)

Author keywords

Adolescents; HIV; HIV vaccines

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADOLESCENT; ADULT; AFRICA; ARTICLE; CHILD BEHAVIOR; COHORT ANALYSIS; COUNSELING; FEASIBILITY STUDY; FEMALE; GROUPS BY AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SYPHILIS;

ADOLESCENT; ADULT; AIDS VACCINES; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; PATIENT DROPOUTS; PATIENT PARTICIPATION; QUESTIONNAIRES; SOUTH AFRICA;

EID: 44949221619     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2007.11.144     Document Type: Article

References (20)

1. UNAIDS 2004 Report on the global AIDS epidemic. Focus: HIV and young people: the threat for today's youth. http://www.unaids.org/bangkok2004/GAR2004_pdf/Focus_youth_en.pdf
2. World Health Organisation. Child and Adolescent Health and Development. http://www.who.int/child-adolescent-health/HIV/HIV_adolescents.htm
3. Report: National HIV and Syphilis Antenatal Sero-Prevalence Survey in South Africa 2005, Department of Health, Republic of South Africa. www.doh.gov.za/docs/reports/2005/hiv.pdf
4. McClure C.A., Gray G., Rybczyk G.K., et al. Challenges to conducting HIV preventative vaccine trials with adolescents. J Acquir Immune Defic Syndr 36 (2004) 726-733
5. Jaspan H.B., Gray G.E., Robinson A.K., et al. Scientific justification for the participation of children and adolescents in IV-1 vaccine trials in South Africa. S Afr Med J 95 (2005) 685-687
6. Slack C., Strode A., Grant C., et al. Implications of the ethical-legal framework for adolescent HIV vaccine trials-report of a consultative forum. S Afr Med J 95 (2005) 682-684
7. Van Wyk C. The participation of minors in preventative HIV research trials in South Africa: legal and human rights considerations. Med Law 22 (2003) 589-598
8. Bekker L.G., Jaspan H., McIntyre J., et al. Adolescents and HIV vaccine trials: what are the clinical trials site issues?. J Int Assoc Physicians AIDS Care 4 (2005) 93-97
9. Swartz L., Kagee Z., Smit J., et al. Social and behavioural aspects of child and adolescent participation in HIV vaccine trials. J Int Assoc Physicians AIDS Care 4 (2005) 89-92
10. Stanford P.D., Monte D.A., Briggs F.M., et al. Recruitment and retention of adolescent participants in HIV research: findings from the REACH (Reaching for Excellence in Adolescent Care and Health) Project. J Adolesc Health 32 (2003) 192-203
11. De Souza C.T.V., Lowndes C.M., Szwarcwald C.L., et al. Willingness to participate in HIV vaccine trials among a sample of men who have sex with men, with and without a history of commercial sex, Rio de Janiero, Brazil. AIDS Care 15 (2003) 539-548
12. Bartholow B.N., MacQueen K.M., Douglas Jr. J.M., et al. Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men. J Acquir Immune Defic Syndr Hum Retrovirol 16 (1997) 108-115
13. Murphy D.A., Hoffman D., Seage III G.R., et al. Improving comprehension for HIV vaccine trial information among adolescents at risk of HIV. AIDS Care 19 (2007) 42-51
14. Sahay S., Mehendale S., Sane S., et al. Correlates of HIV vaccine trial participation: an Indian perspective. Vaccine 23 (2005) 1351-1358
15. Kiwanuka N., Kigozi G., Birx D., et al. Knowledge about vaccines and willingness to participate in preventative HIV vaccine trials: a population-based study, Rakai, Uganda. J Acquir Immune Defic Syndr 36 (2004) 721-725
16. Jaspan H.B., Berwick J.R., Myer L., et al. Adolescent HIV prevalence, sexual risk, and willingness to participate in HIV vaccine trials. J Adolesc Health 39 (2006) 642-28
17. Wood R., Middelkoop K., Myer L., et al. The burden of undiagnosed pulmonary tuberculosis (TB) in an African community with high HIV-prevalence: implications for TB control. Am J Respir Crit Care Med 175 (2007) 87-93
18. Jenkins R.A., Suchada C., Morgan P.A., et al. Motivation, recruitment and screening of volunteers for a Phase I/II HIV preventive vaccine trial in Thailand. J Acquir Immune Defic Syndr Hum Retrovirol 18 (1998) 171-177
19. Dixon D.O., Rida W.N., Fast P.E., et al. HIV vaccine trials: some design issues including sample size calculations. J Acquir Immune Defic Syndr 6 (1993) 485-496
20. Heyward W.L., Osmanov S., Saba J., et al. Preparation for phase III HIV vaccine efficacy trials: methods for the determination of HIV incidence. AIDS 8 (1994) 1285-1291